Kimi Iguchi
2020
In 2020, Kimi Iguchi earned a total compensation of $2M as Chief Financial Officer and Treasurer at Sage Therapeutics, a 50% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $206,756 |
|---|---|
| Option Awards | $1,058,096 |
| Salary | $428,067 |
| Stock Awards | $265,388 |
| Other | $10,439 |
| Total | $1,968,746 |
Iguchi received $1.1M in option awards, accounting for 54% of the total pay in 2020.
Iguchi also received $206.8K in non-equity incentive plan, $428.1K in salary, $265.4K in stock awards and $10.4K in other compensation.
Rankings
In 2020, Kimi Iguchi's compensation ranked 5,588th out of 13,090 executives tracked by ExecPay. In other words, Iguchi earned more than 57.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,588 out of 13,090 | 57th |
Division Manufacturing | 2,305 out of 5,617 | 59th |
Major group Chemicals And Allied Products | 921 out of 2,248 | 59th |
Industry group Drugs | 796 out of 1,948 | 59th |
Industry Pharmaceutical Preparations | 592 out of 1,453 | 59th |
Source: SEC filing on April 29, 2021.
Iguchi's colleagues
We found five more compensation records of executives who worked with Kimi Iguchi at Sage Therapeutics in 2020.
2020
Jeffrey Jonas
Sage Therapeutics
Chief Executive Officer
2020
Michael Cloonan
Sage Therapeutics
Chief Operating Officer
2020
Anne Cook
Sage Therapeutics
General Counsel
2020
Albert Robichaud
Sage Therapeutics
Chief Scientific Officer
2020
Barry Greene
Sage Therapeutics
Chief Executive Officer
News
Sage Therapeutics CEO Barry Greene's 2021 pay jumps 469% to $59M
April 28, 2022
Sage Therapeutics CEO Jeffrey Jonas' 2020 pay falls 53% to $4.7M
April 29, 2021
Sage Therapeutics CEO Jeffrey Jonas' 2019 pay rises 1% to $9.9M
April 29, 2020
Sage Therapeutics CEO Jeffrey Jonas' 2018 pay jumps 71% to $9.8M
April 25, 2019